Disorders in Hemostasis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Neonatal bleeding is a common problem encountered in nursery rooms or neonatal incentive care units, especially among premature infants. Furthermore, owing to recent remarkable improvement of neonatology, survival rates of preterm neonates have increased; hence, neonatal bleeding cannot be emphasized enough. Since the total blood volume of neonates is small, bleeding can be one of the causes of morbidities and mortalities. Therefore, rapid diagnosis and immediate therapy is urgently needed. The patient’s medical history including a familial history of a bleeding disorder or of a previously affected infant who suffered from bleeding along with maternal and neonatal drugs can provide important diagnostic clues. Presence of bleeding with or without petechiae and ecchymoses in a healthy term or late preterm infant with thrombocytopenia but normal prothrombin time and activated partial thromboplastin time strongly suggests a congenital bleeding disorder. For a sick infant who is bleeding from multiple sites,an acquired disorder such as disseminated intravascular coagulation is suspected. Intracranial hemorrhage in term or late preterm infants without a history of birth trauma is highly suggestive of coagulation disorders. The purpose of this review is to summarize recent advances in diagnostic methods is as well as basic concepts of neonatal hemostatic disorders. First, an outline of background information will be presented followed by a discussion of primary and secondary hemostatic disorders as well as inherited and acquired disorders.
Abstract
Neonatal bleeding is a common problem encountered in nursery rooms or neonatal incentive care units, especially among premature infants. Furthermore, owing to recent remarkable improvement of neonatology, survival rates of preterm neonates have increased; hence, neonatal bleeding cannot be emphasized enough. Since the total blood volume of neonates is small, bleeding can be one of the causes of morbidities and mortalities. Therefore, rapid diagnosis and immediate therapy is urgently needed. The patient’s medical history including a familial history of a bleeding disorder or of a previously affected infant who suffered from bleeding along with maternal and neonatal drugs can provide important diagnostic clues. Presence of bleeding with or without petechiae and ecchymoses in a healthy term or late preterm infant with thrombocytopenia but normal prothrombin time and activated partial thromboplastin time strongly suggests a congenital bleeding disorder. For a sick infant who is bleeding from multiple sites,an acquired disorder such as disseminated intravascular coagulation is suspected. Intracranial hemorrhage in term or late preterm infants without a history of birth trauma is highly suggestive of coagulation disorders. The purpose of this review is to summarize recent advances in diagnostic methods is as well as basic concepts of neonatal hemostatic disorders. First, an outline of background information will be presented followed by a discussion of primary and secondary hemostatic disorders as well as inherited and acquired disorders.
참고문헌 (49)
- Chalmers EA, "Neonatal coagulation problems", Arch Dis Child Fetal Neonatal Ed, 89, pp.F475~F478 (2004)
- Saxonhouse MA, "The evaluation and management of neonatal coagulation disorders", Semin Perinatol, 33, pp.52~65 (2009)
- Roberts I, "Neonatal thrombocytopenia: causes and management", Arch Dis Child Fetal Neonatal Ed, 88, pp.F359~F364 (2003)
- Andrew M, "Development of the hemostatic system in the neonate and young infant", Am J Pediatr Hematol Oncol, 12, pp.95~104 (1990)
- Andrew M, "Development of the human coagulation system in the full-term infant", Blood, 70, pp.165~172 (1987)
- Andrew M, "Development of the human coagulation system in the healthy premature infant", Blood, 72, pp.1651~1657 (1988)
- Reverdiau-Moalic P, "Evolution of blood coagulation activators and inhibitors in the healthy human fetus", Blood, 88, pp.900~906 (1996)
- Kenet G, "Bleeding disorders in neonates", Haemophilia, 16(5), pp.168~175 (2010)
- Mueller-Eckhardt C, "348 cases of suspected neonatal alloimmune thrombocytopenia", Lancet, 1, pp.363~366 (1989)
- Spencer JA, "Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis", Aust N Z J Obstet Gynaecol, 41, pp.45~55 (2001)
- Bussel JB, "Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia", Semin Perinatol, 33, pp.35~42 (2009)
- Kuhle S, "Hemostatic disorders of the newborn. In Avery’s diseases of the newborn. 8th ed", pp.1145~1179 (2005), Philadelphia: Elsevier Saunders
- 최준석, "항-HLA-B35 항체에 의한 신생아 동종면역성 혈소판 감소증 1례", 대한신생아학회지, 16(2), pp.248~254 (2009), 대한신생아학회
- Murphy MF, "Advances in the management of alloimmune thrombocytopenia", Br J Haematol, 136, pp.366~378 (2007)
- Bussel J, "Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia", J Thromb Haemost, 7(1), pp.253~257 (2009)
- Burrows RF, "Fetal thrombocytopenia and its relation to maternal thrombocytopenia", N Engl J Med, 329, pp.1463~1466 (1993)
- Bussel JB, "Antenatal management of fetal alloimmune and autoimmune thrombocytopenia", Transfus Med Rev, 4, pp.149~162 (1990)
- Baehner RL, "Hemophilia in the first year of life", N Engl J Med, 275, pp.524~528 (1966)
- Ljung RC, "Prenatal diagnosis of haemophilia", Haemophilia, 5, pp.84~87 (1999)
- Kulkarni R, "Perinatal management of newborns with haemophilia", Br J Haematol, 112, pp.264~274 (2001)
- Cox Gill J, "Diagnosis and treatment of von Willebrand disease", Hematol Oncol Clin North Am, 18, pp.1277~1299 (2004)
- Sadler JE, "A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis", Thromb Haemost, 71, pp.520~525 (1994)
- Gazengel C, "Treatment of type III von Willebrand’s disease with solvent", detergent-treated factor VIII concentrates, 1988, pp.30, 225~227
- Nichols WC, "von Willebrand disease", Medicine (Baltimore), 76, pp.1~20 (1997)
- Rha JY, "Three cases of factor XI deficiency", Korean J Pediatr Hematol Oncol, 8, pp.344~348 (2001)
- Kim HJ, "A case of congenital factor VII deficiency associated with intraventricular hemorrhage and hydrocephalus", J Korean Pediatr Soc, 41, pp.1726~1730 (1998)
- Cho KC, "A case of combined congenital deficiency of factor V and factor VIII", J Korean Pediatr Soc, 39, pp.1162~1167 (1996)
- Townsend CW, "The haemorrhagic disease of the newborn", Arch Pediatr, 11, pp.559~565 (1894)
- McNinch A, "Vitamin K deficiency bleeding: early history and recent trends in the United Kingdom", Early Hum Dev, 86(1), pp.63~65 (2010)
- Sutor AH, "Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric", Perinatal Subcommittee. International Society on Thrombosis and Haemostasis, 1999, pp.81, 456~461
- Van Winckel M, "Vitamin K, an update for the paediatrician", Eur J Pediatr, 168, pp.127~134 (2009)
- American Academy of Pediatrics, "Committee on Nutrition. Pediatric nutrition handbook. 6th ed", pp.468~471 (2009), Elk Grove Village: American Academy of Pediatrics
- Shapiro AD, "Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors", J Pediatr, 109, pp.675~680 (1986)
- von Kries R, "Neonatal vitamin K prophylaxis. Report of Scientific and Standardization, Subcommittee on Perinatal Haemostasis", Thromb Haemost, 69, pp.293~295 (1993)
- Clark FI, "Twenty-seven years of experience with oral vitamin K1 therapy in neonates", J Pediatr, 127, pp.301~304 (1995)
- Vietti TJ, "Observation on the prophylactic use of vitamin K in the newborn", J Pediatr, 56, pp.343~346 (1960)
- Comelissen EA, "Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K", Acta Paediatr, 82, pp.656~699 (1993)
- Schubiger G, "Oral vitamin K1 prophylaxis for newborns with a new mixedmicellar preparation of phylloquinone: 3 years experience in Switzerland", Eur J Pediatr, 158, pp.599~602 (1999)
- Lippi G, "Vitamin K in neonates: facts and myths", Blood Transfus, 9, pp.4~9 (2011)
- Bick RL, "Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care", Clin Appl Thromb Hemost, 8, pp.1~31 (2002)
- Veldman A, "Disseminated intravascular coagulation in term and preterm neonates", Semin Thromb Hemost, 36, pp.419~428 (2010)
- Levi M, "Disseminated intravascular coagulation", N Engl J Med, 341, pp.586~592 (1999)
- Kreuz W, "Neonatal sepsis: a challenge in hemostaseology", Semin Thromb Hemost, 25, pp.531~535 (1999)
- von Kries R, "Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation", Eur J Pediatr, 144, pp.191~194 (1985)
- Schmidt B, "A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome", Am J Respir Crit Care Med, 158, pp.470~476 (1998)
- Fourrier F, "Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation", Chest, 104, pp.882~888 (1993)
- Newall F, "Unfractionated heparin therapy in infants and children", Pediatrics, 123, pp.e510~e518 (2009)
- Martchenke J, "Heparin-induced thrombocytopenia in neonates", Neonatal Netw, 24, pp.33~37 (2005)
- Risch L, "Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children", Thromb Res, 118, pp.123~135 (2006)